Probiotics promote gut health through stimulation of epithelial innate immunity

被引:273
作者
Pagnini, Cristiano [2 ]
Saeed, Rubina [2 ]
Bamias, Giorgos [1 ,2 ]
Arseneau, Kristen O. [1 ]
Pizarro, Theresa T. [1 ,3 ]
Cominelli, Fabio [1 ]
机构
[1] Case Western Reserve Univ, Digest Hlth Ctr, Cleveland, OH 44106 USA
[2] Univ Virginia Hlth Syst, Digest Hlth Res Ctr, Charlottesville, VA 22908 USA
[3] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA
基金
美国国家卫生研究院;
关键词
Crohn's disease; cytokines; INFLAMMATORY-BOWEL-DISEASE; TUMOR-NECROSIS-FACTOR; CROHNS-DISEASE; FACTOR-ALPHA; KAPPA-B; MURINE; MODEL; RESPONSES; BACTERIA; COLITIS;
D O I
10.1073/pnas.0910307107
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Probiotic formulations are widely available and have a variety of proposed beneficial effects, including promotion of gut health. The mechanisms of action of probiotic bacteria in the intestine are still unclear but are generally attributed to an antiinflammatory effect. Here, we demonstrate that the multiple probiotic formulation VSL#3 prevents the onset of intestinal inflammation by local stimulation of epithelial innate immune responses (i.e., increased production of epithelial-derived TNF-alpha and restoration of epithelial barrier function in vivo). We also demonstrate that probiotic bacteria stimulate epithelial production of TNF-alpha and activate NF-kappa B in vitro. Our results support the hypothesis that probiotics promote gut health through stimulation, rather than suppression, of the innate immune system. Furthermore, our findings provide the perspective that defects in innate immunity may play a critical role in the pathogenesis and progression of intestinal disorders, such as inflammatory bowel disease.
引用
收藏
页码:454 / 459
页数:6
相关论文
共 32 条
[1]   New concepts in the pathophysiology of inflammatory bowel disease [J].
Bamias, G ;
Nyce, MR ;
De La Rue, SA ;
Cominelli, F .
ANNALS OF INTERNAL MEDICINE, 2005, 143 (12) :895-904
[2]   VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis [J].
Bibiloni, R ;
Fedorak, RN ;
Tannock, GW ;
Madsen, KL ;
Gionchetti, P ;
Campieri, M ;
De Simone, C ;
Sartor, RB .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (07) :1539-1546
[3]   Tumor necrosis factor α-dependent up-regulation of Lrh-1 and Mrp3(Abcc3) reduces liver injury in obstructive cholestasis [J].
Bohan, A ;
Chen, WS ;
Denson, LA ;
Held, MA ;
Boyer, JL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (38) :36688-36698
[4]   Antibody blockade of ICAM-1 and VCAM-1 ameliorates inflammation in the SAMP-1/Yit adoptive transfer model of Crohn's disease in mice [J].
Burns, RC ;
Rivera-Nieves, J ;
Moskaluk, CA ;
Matsumoto, S ;
Cominelli, F ;
Ley, K .
GASTROENTEROLOGY, 2001, 121 (06) :1428-1436
[5]   The two faces of IKK and NF-κB inhibition:: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion [J].
Chen, LW ;
Egan, L ;
Li, ZW ;
Greten, FR ;
Kagnoff, MF ;
Karin, M .
NATURE MEDICINE, 2003, 9 (05) :575-581
[6]   Defects in mucosal immunity leading to Crohn's disease [J].
Cobrin, GM ;
Abreu, MT .
IMMUNOLOGICAL REVIEWS, 2005, 206 :277-295
[7]   Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora [J].
Cong, YZ ;
Weaver, CT ;
Lazenby, A ;
Elson, CO .
JOURNAL OF IMMUNOLOGY, 2002, 169 (11) :6112-6119
[8]   Inflammatory bowel disease: Etiology and pathogenesis [J].
Fiocchi, C .
GASTROENTEROLOGY, 1998, 115 (01) :182-205
[9]  
FULLER R, 1989, J APPL BACTERIOL, V66, P365
[10]   Molecular quantification of lactic acid bacteria in fermented milk products using real-time quantitative PCR [J].
Furet, JP ;
Quénée, P ;
Tailliez, P .
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, 2004, 97 (02) :197-207